Natco Pharma Gains 3% After $8 Million Investment in US Biotech Firm eGenesis
Shares of Natco Pharma Ltd. rose by 3% to a day’s high of Rs 1,555 on 4th September after the company announced that its wholly-owned...
Tag : Natco Pharma
Natco Pharma Shares Tumble 4% Despite Stellar Q2 Earnings; Net profit Skyrocketed 550% YoY
On 15 November, despite posting stellar Q2FY24 earnings, Natco Pharma shares were trading in the red and 4% below their previous level. The pharmaceutical company’s...
Natco Pharma Shares Fall 1% as USFDA Issues 8 Observation
Shares of Natco Pharma tumbled 1% on 20 October after the USFDA (US Food and Drug Administration) issued 8 observations for its Hyderabad unit. The...
Natco Pharma Shares Tumble 3% Over US Antitrust Lawsuit
Natco Pharma shares hit a slump on 8 September after the company was named a defendant in an antitrust lawsuit in the United States of...
Natco Pharma Shares Rise More Than 1% After Board Approves Share Buyback Proposal
Shares of Natco Pharma rose 1.12% on Friday, March 10, after the company informed that its board had approved a proposal to buy back up...
Natco Pharma Share Jumps for 2nd Day on Share Buyback Plan
Natco Pharma shares rose more than 2% in morning trade on March 3, a day after the company said it would consider a share buyback...
Natco Pharma Shares Up 4% on Filing Generic Version of Oncology Drug in US
Shares of Natco Pharma rose 4.5% to Rs 549 a share in intraday trade on Monday after the company submitted a generic version of an...
Natco Pharma Gains 9%, Launches Generic Version of Revlimid in US
Shares of Natco Pharma rallied 9 per cent to Rs 920 on the BSE in Tuesday’s intra-day trade after the company launched its first generic...
Natco Pharma launches generic version of Teriflunomide
Natco Pharma has launched a generic version of Teriflunomide, under its brand Denopsy. It is used for treating Relapsing and Remitting forms of Multiple Sclerosis (RRMS)....
Natco Pharma seeks USFDA nod for hepatitis drug
Natco Pharma has filed an abbreviated new drug application (ANDA) for Sofosbuvir Tablets, 400mg, with the United States Food and Drug Administration (USFDA). The company...